SCHEMBL371255

SCHEMBL371255

CC(C)CC(N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7032277 1.00
SCHEMBL1988780 1.00
Phosphoric Acid SCHEMBL20775156 0.88 LAP3 (0.52)
SCHEMBL7166170 0.82 LMNA (0.48)
SCHEMBL26755328 0.82
SCHEMBL13607055 0.81
SCHEMBL7911546 0.77 ALDH1A1 (0.42)
SCHEMBL12380275 0.76
SCHEMBL27362930 0.76
SCHEMBL10077126 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3921319-B1 IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEIGENE LTD (KY) 2024-03-06 EP claimed
CN-113912524-B Polypeptide compound containing sulfur amide and synthesis method thereof 华东师范大学 2023-12-01 CN claimed
EP-4274567-A1 FORMS AND FORMULATIONS OF A TYROSINE KINASE NON-RECEPTOR 1 (TNK1) INHIBITOR Sumitomo Pharma Oncology, Inc. (US) 2023-11-15 EP claimed
US-20230167117-A1 IMIDAZO[2,1-F][1,2,4]TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BEONE MEDICINES I GMBH (CH) 2023-06-01 US claimed
US-20230167109-A1 Aminopiperidine Amides, Derivatives, Compositions, and Uses Related to CXCR4 Modulation UNIV EMORY (US) 2023-06-01 US claimed
WO-2022150801-A1 FORMS AND FORMULATIONS OF A TYROSINE KINASE NON-RECEPTOR 1 (TNK1) INHIBITOR SUMITOMO PHARMA ONCOLOGY, INC. (US) 2022-07-14 WO claimed
EP-3921319-A1 IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST BeiGene, Ltd. (KY) 2021-12-15 EP claimed
WO-2021217143-A1 AMINOPIPERIDINE AMIDES, DERIVATIVES, COMPOSITIONS, AND USES RELATED TO CXCR4 MODULATION EMORY UNIVERSITY (US) 2021-10-28 WO claimed
CN-113423708-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR7 agonists 百济神州有限公司 2021-09-21 CN claimed
EP-3836971-A1 CONJUGATES AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2021-06-23 EP claimed
US-20060100431-A1 Biologically active compounds AMURA THERAPEUTICS LIMITED (GB) 2006-05-11 US claimed
WO-2006042653-A1 HETEROCYCLYL-SUBSTITUTED NONADEPSIPEPTIDES AICURIS GMBH & CO. KG (DE) 2006-04-27 WO claimed
WO-2006042654-A1 SUBSTITUTED NONADEPSIPEPTIDES AICURIS GMBH & CO. KG (DE) 2006-04-27 WO claimed
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed
EP-0942742-A4 THERAPEUTIC COMPOSITIONS FOR TREATMENT OF CANCER CANCER TREAT S INTERNAT (CH) 2003-01-08 EP claimed
EP-1192162-A2 TAXANE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF INDENA S.p.A. (IT) 2002-04-03 EP claimed
WO-2001002407-A2 TAXANE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF INDENA S.P.A. (IT) 2001-01-11 WO claimed
EP-0942742-A1 THERAPEUTIC COMPOSITIONS FOR TREATMENT OF CANCER Cancer Treatments International (CH) 1999-09-22 EP claimed
WO-1998006421-A1 THERAPEUTIC COMPOSITIONS FOR TREATMENT OF CANCER CANCER TREATMENTS INTERNATIONAL (CH) 1998-02-19 WO claimed